Active	Status	Sponsor type	Region	Phase	Filter
15 Active 14 Inactive 29 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

6 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Gerven, Laura H Van
NCT04670172: Real-Life Chronic Rhinosinusitis Outcome Registry	Recruiting	N/A	4550	Europe		Change Accelerator in Respiratory Care	Chronic Rhinosinusitis (Diagnosis)	06/24	12/24
SPAT_AI, NCT05918354: Development and Evaluation of an Artificial Intelligence Model for the Diagnosis of Aeroallergies	Completed	N/A	993	Europe	Skin Prick Automated Test	Hippocreates	Allergy	09/24	09/24
Hellings, Peter W
PREPARED-1, NCT06339008: A Study of Lebrikizumab in Adult Participants With Perennial Allergic Rhinitis	Recruiting	3	450	Europe, US, RoW	LY3650150, Placebo, Standard therapy for INCS	Eli Lilly and Company	Perennial Allergic Rhinitis (PAR)	05/25	05/26
ANCHOR-1, NCT05274750 / 2021-005037-16: Efficacy and Safety of Depemokimab (GSK3511294) in Participants With Chronic Rhinosinusitis With Nasal Polyps Jul 2024 - Dec 2024 : Acceptance of regulatory submission in US for CRSwNP	Completed	3	276	Europe, Canada, Japan, US, RoW	Depemokimab (GSK3511294), Placebo	GlaxoSmithKline, GlaxoSmithKline Research & Development Limited	Nasal Polyps	07/24	08/24
NCT04670172: Real-Life Chronic Rhinosinusitis Outcome Registry	Recruiting	N/A	4550	Europe		Change Accelerator in Respiratory Care	Chronic Rhinosinusitis (Diagnosis)	06/24	12/24
SPAT_AI, NCT05918354: Development and Evaluation of an Artificial Intelligence Model for the Diagnosis of Aeroallergies	Completed	N/A	993	Europe	Skin Prick Automated Test	Hippocreates	Allergy	09/24	09/24